首页 正文

Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?

{{output}}
Introduction: The strategic addition of immune checkpoint inhibitors (ICIs) to chemotherapy (CT) offers a potential paradigm shift in the treatment of elderly cancer patients. This systematic review evaluates the impact of ICIs c... ...